The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis
Isidori, Alessandro, Merli, Francesco, Angrilli, Francesco, Ferrara, Felicetto, Alesiani, Francesco, Visani, GiuseppeVolume:
52
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2010.525726
Date:
January, 2011
File:
PDF, 141 KB
english, 2011